GR852834B - - Google Patents

Info

Publication number
GR852834B
GR852834B GR852834A GR850102834A GR852834B GR 852834 B GR852834 B GR 852834B GR 852834 A GR852834 A GR 852834A GR 850102834 A GR850102834 A GR 850102834A GR 852834 B GR852834 B GR 852834B
Authority
GR
Greece
Application number
GR852834A
Other languages
Greek (el)
Inventor
Giancarlo Sportoletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of GR852834B publication Critical patent/GR852834B/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GR852834A 1984-11-29 1985-11-25 GR852834B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (en) 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY

Publications (1)

Publication Number Publication Date
GR852834B true GR852834B (en) 1986-03-27

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
GR852834A GR852834B (en) 1984-11-29 1985-11-25

Country Status (12)

Country Link
EP (1) EP0236329A1 (en)
JP (1) JPS62501703A (en)
KR (1) KR870700608A (en)
CN (1) CN85109554A (en)
AU (1) AU5231186A (en)
DK (1) DK346486D0 (en)
ES (1) ES8701717A1 (en)
GR (1) GR852834B (en)
IT (1) IT1196348B (en)
PT (1) PT81566B (en)
WO (1) WO1986003199A1 (en)
ZA (1) ZA859035B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (en) * 1990-09-12 1994-09-12 Depha Team Srl DERIVATIVES OF 5-AMINOSALICYLIC ACID (5-ASA) FOR THE THERAPY OF CHRONIC INTESTINAL INFLAMMATIONS
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (en) * 1995-09-01 1997-10-31 Synthelabo USE OF SULPHASALAZINE AND ITS METABOLITES FOR THE MANUFACTURE OF A MEDICAMENT USEFUL IN THE TREATMENT OF VENOUS INSUFFICIENCY AND VENOUS ULCERS
JP3854154B2 (en) * 2000-04-19 2006-12-06 ニューロテック カンパニー リミテッド Compounds, compositions and methods for preventing neurodegeneration resulting from acute and chronic damage to the central nervous system
US6573402B1 (en) 2000-04-20 2003-06-03 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
EP1175906B1 (en) * 2000-07-18 2005-11-09 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blood flow improvers and thrombosis preventives or remedies comprising glucosamine
DE60136260D1 (en) 2001-01-19 2008-12-04 Apex Biotechnology Corp Non-enzymatic detergent-containing disposable electrical strips for the detection of uric acid or hemoglobin, as well as methods for the production and use of the same
CA2465978C (en) 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
CA2490120C (en) 2002-06-19 2010-06-01 Neurotech Co., Ltd. Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
KR100668111B1 (en) 2005-07-28 2007-01-12 (주)에스에이치제약 New aminosalicylic acid analogs, it's pharmaceutically acceptable salts and their preparations
CN101538218B (en) * 2006-04-13 2013-05-29 纽若泰克制药株式会社 Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
CN100422721C (en) * 2006-05-26 2008-10-01 南京大学 Aluminium ion investigating method using glycosyl naphthol
EP2201946A4 (en) * 2007-10-23 2012-01-25 Inst Med Molecular Design Inc Pai-1 production inhibitor
KR100852962B1 (en) 2007-11-12 2008-08-20 주식회사 뉴로테크 Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
JP5688015B2 (en) * 2008-07-08 2015-03-25 カタバシス ファーマシューティカルズ,インコーポレイテッド Fatty acid acetylated salicylates and uses thereof
KR101204108B1 (en) * 2009-02-09 2012-11-22 주식회사 지엔티파마 Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
SG10201500431SA (en) 2009-09-01 2015-03-30 Catabasis Pharmaceuticals Inc Fatty acid niacin conjugates and their uses
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
CN104603100A (en) * 2012-05-23 2015-05-06 塞利克斯比奥私人有限公司 Compositions and methods for treatment of inflammatory bowel disease
WO2014070859A1 (en) 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
BR112021012707A2 (en) * 2018-12-28 2021-09-08 Gnt Pharma Co., Ltd. COMPOSITIONS AND METHODS TO TREAT NEURODEGENERATIVE DISORDERS
CN111116395B (en) * 2019-12-27 2023-04-07 湖北工业大学 Multi-iodo aromatic acid compound and application thereof in resisting adenovirus 7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (en) * 1964-06-09 1966-11-02
NL7008623A (en) * 1969-06-25 1970-12-29
JPS5640710B2 (en) * 1973-01-18 1981-09-22
JPS6056130B2 (en) * 1978-03-20 1985-12-09 久光製薬株式会社 Novel salicylic acid derivatives
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
IT1196348B (en) 1988-11-16
JPS62501703A (en) 1987-07-09
ES8701717A1 (en) 1986-12-01
DK346486A (en) 1986-07-21
WO1986003199A1 (en) 1986-06-05
KR870700608A (en) 1987-12-30
PT81566B (en) 1987-04-07
AU5231186A (en) 1986-06-18
PT81566A (en) 1985-12-01
DK346486D0 (en) 1986-07-21
CN85109554A (en) 1986-07-23
IT8423799A0 (en) 1984-11-29
ZA859035B (en) 1986-08-27
EP0236329A1 (en) 1987-09-16
ES549359A0 (en) 1986-12-01

Similar Documents

Publication Publication Date Title
DE3521087C2 (en)
GR852496B (en)
DE3440960C2 (en)
GR850212B (en)
GR852834B (en)
DE3419894C2 (en)
AT379850B (en)
GR852324B (en)
GR850852B (en)
DE3405179C2 (en)
GR850718B (en)
GR850412B (en)
GR852248B (en)
DE3432102C2 (en)
DE3426102C2 (en)
DE3590506T1 (en)
DE3513588C2 (en)
DE3511422C2 (en)
DE3402383C2 (en)
GR851522B (en)
DE3415207C2 (en)
AU2557584A (en)
GR73807B (en)
GR74224B (en)
GR76638B (en)